| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2023 4th Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2023 3rd Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2023 2nd Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2023 1st Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2022 4th Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2022 3rd Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2022 2nd Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2022 AMENDED |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2022 1st Quarter - Report |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — | |
| 2021 AMENDED |
GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | — |